Using automated extraction of hepatitis B tests for surveillance: Evidence of decreasing incidence of acute hepatitis B in England

Epidemiology and Infection

Volumn 140, Issue 6, 2012, Pages 1075-1086

  Brant, L J ^a   Hurrelle, M ^a   Collins, S ^a   Klapper, P E ^b   Ramsay, M E ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

England; epidemiology; hepatitis B; incidence; surveillance

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ASIAN; ASYMPTOMATIC INFECTION; AUTOMATION; BLOOD TRANSFUSION; BODY PIERCING; DATA EXTRACTION; DIAGNOSTIC TEST; DISEASE SURVEILLANCE; DRUG USE; EXPOSURE; FAMILY HISTORY; FEMALE; HEPATITIS B; HETEROSEXUALITY; HUMAN; INCIDENCE; INJECTING DRUG USE; LABORATORY; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; OCCUPATIONAL HAZARD; RISK FACTOR; SEX DIFFERENCE; SOUTH ASIAN; SURGERY; TATTOO; TRAVEL; UNITED KINGDOM; VERTICAL TRANSMISSION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; DATA COLLECTION; ENGLAND; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HUMANS; IMMUNOGLOBULIN M; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; QUESTIONNAIRES; RISK FACTORS; SENTINEL SURVEILLANCE; YOUNG ADULT;

EID: 84861100405     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268811001683     Document Type: Article

References (43)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of Viral Hepatitis 2004; 11: 97-107.
2. Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. Journal of Hepatology 2003; 39 (Suppl. 1) : S64-S69.
3. Hyams KC. Risks of chronicity following acute hepatitis B virus infection : A review. Clinical Infectious Diseases 1995; 20: 992-1000.
4. World Health Organisation. Hepatitis B vaccines. WHO position paper. Weekly Epidemiological Record 2004; 28: 255-263.
5. Department of Health. Immunisation Against Infectious Disease, 3rd edn. ed. Salisbury DM, Ramsay ME. London: The Stationery Office, 2006.
6. Zuckerman J, et al. Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe? Lancet Infectious Diseases 2007; 7: 410-419.
7. Mangtani P, Heptonstall J, Hall AJ. Enhanced surveillance of acute symptomatic hepatitis B in England and Wales. Communicable Disease and Public Health 1998; 1: 114-120.
8. Balogun MA, et al. Acute hepatitis B infection in England and Wales: 1985-96. Epidemiology and Infection 1999; 122: 125-131.
9. Hahne S, et al. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy. Journal of Clinical Virology 2004; 29: 211-220.
10. Cooke G, Main J, Thursz MR. Treatment for hepatitis B. British Medical Journal 2010; 340: 87-91.
11. Health Protection Agency. Hepatitis B diagnostic serology in the immunocompetent (including hepatitis B in pregnancy). National Standard Method 2010; VSOP 4.
12. Galli C, et al. What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology? Journal of Medical Virology 2008; 80: 974-979.
13. Colloredo G, et al. Quantitative analysis of IgM anti- HBc in chronic hepatitis B patients using a new 'grayzone' for the evaluation of 'borderline' values. Journal of Hepatology 1996; 25: 644-648.
14. Health Service Circular. Screening of pregnant women for hepatitis B and immunisation of babies at risk, 22 July 1998.
15. Department of Health. Good practice guidelines for renal dialysis/transplantation units. Prevention and Control of Blood-borne Virus Infection, 2002.
16. National Institute for Clinical Excellence. Fertility : Assessment and treatment for people with fertility problems. London: National Institute for Clinical Excellence, 2004.
17. NHSBT/HPA Epidemiology Unit. Safe supplies : testing the nation, 2008 data. London: Health Protection Agency, 2009.
18. Gunson RN, et al. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. Journal of Clinical Virology 2003; 27: 213-230.
19. Ramsay M, et al. Control of hepatitis B in the United Kingdom. Vaccine 1998; 16 (Suppl.) : S52-S55.
20. Health Protection Agency. Acute hepatitis B in England, annual report for 2008. Health Protection Report, 2009; 3: 6-8.
21. Klompas M, et al. Automated identification of acute hepatitis b using electronic medical record data to facilitate public health surveillance. PLoS ONE 2008; 3: e2626.
22. Brant L, et al. Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection. Epidemiology and Infection 2007; 135: 417-426.
23. Brant L, et al. Where are people being tested for anti- HCV in England? Results from sentinel laboratory surveillance. Journal of Viral Hepatitis 2008; 15: 729-739.
24. Mortimer JY, Salathiel JA. 'Soundex' codes of surnames provide confidentiality and accuracy in a national HIV database. Communicable Disease Report. CRD Review 1995; 5: R183-R186.
25. Cummins C, et al. An assessment of the Nam Pehchan computer program for the identification of names of south Asian ethnic origin. Journal of Public Health Medicine 1999; 21: 401-406.
26. Polakoff S, Tillett H. Routine laboratory reports of patients with acute hepatitis B as indicators of incidence of the disease. Journal of Infection 1984; 8: 44-48.
27. Hahne SJ, et al. Hepatitis B virus transmission in The Netherlands: A population-based, hierarchical casecontrol study in a very low-incidence country. Epidemiology and Infection 2008; 136: 184-195.
28. Diel R, Helle J, Gottschalk R. Transmission of hepatitis B in Hamburg, Germany, 1998-2002: A prospective, population-based study. Medical Microbiology and Immunology 2005; 194: 193-199.
29. Polakoff S. Decrease in acute hepatitis B incidence in England and Wales in 1985-86. Lancet 1987; 1: 380.
30. Hickman M, et al. Injecting drug use in Brighton, Liverpool, and London: best estimates of prevalence and coverage of public health indicators. Journal of Epidemiology and Community Health 2004; 58: 766-771.
31. Incidence of acute hepatitis B - United States, 1990-2002. Morbidity and Mortality Weekly Report 2004; 52: 1252-1254.
32. Ramsay ME, Rushdy AA, Harris HE. Surveillance of hepatitis B: An example of a vaccine preventable disease. Vaccine 1998; 16 (Suppl.) : S76-S80.
33. Custer B, et al. Global epidemiology of hepatitis B virus. Journal of Clinical Gastroenterology 2004; 38: S158-S168.
34. Hutchinson SJ, et al. Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons. Vaccine 2004; 23: 210-214.
35. Hope VD, et al. Improving targeted hepatitis B vaccination. Rapid response. British Medical Journal 2004 (http://bmj.bmjjournals.com/cgi/eletters/ 329/7474/1059).
36. Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, CDSC Northern Ireland, and CRDHB. Shooting up. Infections among injecting drug users in the United Kingdom 2008. An update, October 2009. London: Health Protection Agency, 2009.
37. Robinson T, et al. The New Zealand Hepatitis B Screening Programme: screening coverage and prevalence of chronic hepatitis B infection. New Zealand Medical Journal 2005; 118: U1345.
38. Gjorup IE, et al. Changing epidemiology of HBV infection in Danish children. Journal of Infection 2003; 47: 231-235.
39. Hong Z, et al. Epidemiological study of hepatitis B virus infection in Manitoba, Canada, 1992-2003. European Journal of Clinical Microbiology & Infectious Diseases 2005; 24: 464-470.
40. Pitigoi D, et al. Trends in hepatitis B incidence in Romania, 1989-2005. Eurosurveillance 2008; 13: 8012.
41. Salleras L, et al. Dramatic decline in acute hepatitis B infection and disease incidence rates among adolescents and young people after 12 years of a mass hepatitis B vaccination programme of pre-adolescents in the schools of Catalonia (Spain). Vaccine 2005; 23: 2181-2184.
42. Gerlich WH, Glebe D, Schuttler CG. Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. Journal of Viral Hepatitis 2007; 14 (Suppl. 1) : 16-21.
43. Rodella A, et al. Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B. Journal of Clinical Virology 2006; 37: 206-212.